LARRY KRAMER: Open Payments
NPI 1134118664 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 23 payments from 9 companies in 2025. Trend: 2023 $323 · 2024 $426 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Novo Nordisk Inc | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Abbott Laboratories | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 1 | $22 |
Products named: BREZTRI, XIFAXAN, Kerendia, VOQUEZNA, FREESTYLE LIBRE 3, VRAYLAR, MOUNJARO, Ozempic.
Industry payments across MD — which companies pay providers there.
